Basic & Clinical Medicine ›› 2019, Vol. 39 ›› Issue (2): 277-280.
Previous Articles Next Articles
Hai-Fang WUXiang-Yu MENG2,Heng-Yi Xu2, 2
Received:
Revised:
Online:
Published:
Abstract: Endometrial carcinoma (EC) is one of the most commen gynecological cancer, Its subtype non-estrogen-dependent endometrial carcinoma (type II) is usually associated with gene abnormalities such as P53 gene mutation and HER-2 overexpression. Molecular targeted therapy may improve the therapeutic effect and prognosis of type II endometrial carcinoma.
Key words: Type II endometrial carcinoma, Gene mutation, Targeted therapy
Hai-Fang WU Xiang-Yu MENG Heng-Yi Xu. Research progress on gene mutations and targeted therapy of type II endometrial carcinoma[J]. Basic & Clinical Medicine, 2019, 39(2): 277-280.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/
http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2019/V39/I2/277